230 likes | 247 Views
Conducted at Mahatma Gandhi Cancer Hospital in India, this survey highlights barriers to practicing interstitial brachytherapy as an alternative treatment mode. It compares awareness, time constraints, expertise availability, cost issues, and resource availability among practitioners and non-practitioners. The study emphasizes the importance of interstitial brachytherapy for cases unsuitable for standard intracavitary brachytherapy, emphasizing its safety, efficacy, and relevance in cancer care. The survey aims to encourage the adoption of this procedure in more healthcare facilities to enhance treatment options for gynecological malignancies.
E N D
FEASIBILITY AND ACCEPTANCE OF INTERSTITIAL BRACHYTHERAPY FOR GYNECOLOGICAL MALIGNANCIES IN CANCER CENTERS [INDIA]- A SURVEY Dr. Kanhu Charan Patro Consultant- Radiation Oncology MAHATMA GANDHI CANCER HOSPITAL VISAKHAPATNAM Mr.E.B.Rajmohon CHIEF PHYSICYST MAHATMA GANDHI CANCER HOSPITAL VISAKHAPATNAM
BACKGROUND • Cancer Cervix is very common in our country. • EBRT followed by intracavitray brachytherapy is the evidence based standard of care. • Some cases are not suitable for intracavitray brachytherapy and left as such or unnecessary surgeries and chemotherapy treatment is given without any proper result and evidence. • Interstitial brachytherapy is other mode of treatment to unsuitable cases
OBJECTIVE To find out the barriers to practice interstial brachytherapy [A well explained established simple procedure] in cancer centers in India
MATERIAL & METHOD • Done through telephonic conversation • Around 100 brachytherapy practicing centers in major metro cities and some other cities of India. • Proper data available from 50 centres • Practicing Vs. not practicing • If not practicing then the cause under following headings • Availability of applicator/planning system • Awareness • More Cost • More Time • Casual • Non availability of Expertise
REVIEW LITERTURE/DISCUSSION • This is the first and unique survey of its kind. We have searched the pubmed, medscape etc. not exact study found but some of data found in related article
Nag et.al-IJROBP-1998 • Bulky parametrial extension; • Extensive paravaginal or distal vaginal involvement; • Narrow vagina or poor geometry not accommodating an ovoid (colpostat application) • Endocervical canal not allowing a tandem placement • Prior radiation therapy to the implanted area
Nag et.al • Interstitial brachytherapy can be safely used to treat patients unsuitable for standard intracavitary brachytherapy. • When intracavitary dose distribution is expected to be suboptimal, interstitial brachytherapy is a good alternative • Gynecologic Oncology,Volume 70, Issue 1, July 1998, Pages 27–32
WEAKNESS OF MY SURVEY • VERBAL BIAS • NOT ANALYSED STATISTICALLY. • SAMPLE SIZE IS LESS. • DATA NOT TAKEN FROM ALL BRACHY CENTERS.
Conclusion • It gives best alternative when not suitable for ICRT. • The procedure is safe and can be practiced in all outlaying hospitals. • Cost and time consumption is not much more than all other radiation procedures. • Where ICRT facility available they should upgrade the set up with this facility.
ACKNOWLEDGEMENT • DR.UMESH MAHANSETTY • DR VOONA MURALIKRISHNA • MY ASOOCIATE STAFF • MY PATIENTS • MY HOSPITAL
THANKS Long way to go